Related Experiment Videos
Characterization of mitomycin C-induced gastrointestinal damage. I. In situ recirculation experiment
M Mizuno1, S Kawabata, T Hamaura
1Department of Basic Pharmaceutics, Faculty of Pharmaceutical Sciences, Kyoto University, Japan.
Abstract:
The effects of mitomycin C (MMC), an anti-tumor agent, on the intestinal absorption of various drugs in rats were investigated. Based on microscopic observations, preadministration of a single intravenous dose of MMC (3 mg/kg) caused serious degeneration of epithelial cells, villous atrophy, and mitotic arrest in crypts at 48 hr after pretreatment. At this time point, absorption of sulfanilamide, salicylic acid, cephalexin, and L-tryptophan was shown to be significantly decreased by means of an in situ recirculation technique. The histological changes and the decrease in absorption of sulfanilamide, a model for passively absorbed drugs, were shown to depend on the timing of MMC pretreatment. Maximal effects were observed 48 hr after dosing. The MMC-induced reduction in the absorption of drugs was not a result of differences between treated and control animals with respect to pH of the drug solution, binding of drugs with intraluminal macromolecules, or intestinal mucosal blood flow. The absorption of sulfanilamide from the small intestine in the in situ system correlated well with the wet weight of the small intestine regardless of pretreatment dose or route. This suggests that the change in absorptive surface area of the intestinal mucosa may play a major role in the MMC-induced decrease in absorption capacity of the intestine.
Insights
Mitomycin C (MMC) damages intestinal cells, significantly reducing the absorption of various drugs in rats. This effect is linked to decreased absorptive surface area, impacting drug efficacy.
Area of Science:
- Pharmacology
- Gastroenterology
- Oncology
Background:
- Mitomycin C (MMC) is an anti-tumor agent.
- Intestinal drug absorption is crucial for therapeutic efficacy.
- Understanding drug interactions with anti-cancer agents is vital.
Purpose of the Study:
- To investigate the impact of mitomycin C on intestinal drug absorption in rats.
- To elucidate the mechanisms behind MMC-induced changes in drug absorption.
Main Methods:
- Rats were pretreated with a single intravenous dose of mitomycin C (3 mg/kg).
- Intestinal absorption of sulfanilamide, salicylic acid, cephalexin, and L-tryptophan was assessed using an in situ recirculation technique at 48 hours post-treatment.
- Histological examination of intestinal tissues was performed.
- Factors such as pH, drug binding, and mucosal blood flow were evaluated.
Main Results:
- Mitomycin C caused significant epithelial cell degeneration, villous atrophy, and crypt mitotic arrest in rat intestines 48 hours after administration.
- The absorption of tested drugs was significantly decreased at this time point.
- The reduction in sulfanilamide absorption correlated with intestinal wet weight, suggesting a role for absorptive surface area.
Conclusions:
- Mitomycin C significantly impairs intestinal drug absorption in rats.
- Histological damage and reduced absorptive surface area are key factors in this impairment.
- These findings highlight potential drug interaction issues with mitomycin C therapy.